Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Tools & Technology » Informatics » Incyte Adds SNPs to Abbott Agreement, Signs LifeSeq Gold Deal with Vertex

Incyte Adds SNPs to Abbott Agreement, Signs LifeSeq Gold Deal with Vertex

Mar 09, 2000
Premium

P

ALO ALTO, Calif.--Incyte Pharmaceuticals announced that it has expanded its agreement with Abbott Laboratories to include access to Incyte’s in silico SNP program for an undisclosed amount. The program was developed using a proprietary algorithm to discover common DNA sequence variants by mining Incyte’s LifeSeq Gold database of human genes.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Treatment for Rapid Aging

NPR reports the US Food and Drug Administration has approved a treatment for a genetic disorder that causes rapid aging.

AstraZeneca, Oxford Announce Results Suggesting High Efficacy of Vaccine

Late-stage testing indicates the AstraZeneca and Oxford University SARS-CoV-2 vaccine can have up to 90 percent efficacy, the Associated Press reports.

Criticism Leads to Review of Paper

ScienceInsider reports Nature Communications is reviewing a paper on mentorship following social media criticism arguing it is sexist.

PLOS Papers on SARS-CoV-2 Phylogenies, Swiss Influenza Spread, Infant Meningitis in Ethiopia

In PLOS this week: method to account for sequencing errors in phylogenies, study of influenza A in Switzerland, and more.

Dec
15
Featured Webinar

Case Study: Deployment of High-Throughput SARS-CoV-2 Testing at UC Davis

Sponsored by
UgenTec

Diverse components of the UC Davis campus have been mobilized to deploy HTP testing to provide a safe working environment and keep the pandemic under control.

What's Popular?

In Informatics

  1. Three Investment Banks Initiate Coverage of Biodesix

  2. Prototype GenoShare Tool Aims to Help Patients Understand Risks of Genomic Data Sharing

    Premium

  3. Lurie Children's Hospital Details Migration of Clinical Diagnostics Lab to hg38 Reference Genome

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.